Diagnostic and therapeutic advances have led to much greater awareness of transthyretin cardiac amyloidosis (ATTR-CA). We aimed to characterize changes in the clinical phenotype of patients diagnosed with ATTR-CA over the past 20 years.
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years / Ioannou, Adam; Patel, Rishi K; Razvi, Yousuf; Porcari, Aldostefano; Sinagra, Gianfranco; Venneri, Lucia; Bandera, Francesco; Masi, Ambra; Williams, Georgina E; O'Beara, Sophie; Ganesananthan, Sharmananthan; Massa, Paolo; Knight, Daniel; Martinez-Naharro, Ana; Kotecha, Tushar; Chacko, Liza; Brown, James; Rauf, Muhammad U; Manisty, Charlotte; Moon, James; Lachmann, Helen; Wechelakar, Ashutosh; Petrie, Aviva; Whelan, Carol; Hawkins, Philip N; Gillmore, Julian D; Fontana, Marianna. - In: CIRCULATION. - ISSN 0009-7322. - ELETTRONICO. - 146:22(2022), pp. 1657-1670. [10.1161/CIRCULATIONAHA.122.060852]
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years
Porcari, Aldostefano;Sinagra, Gianfranco;
2022-01-01
Abstract
Diagnostic and therapeutic advances have led to much greater awareness of transthyretin cardiac amyloidosis (ATTR-CA). We aimed to characterize changes in the clinical phenotype of patients diagnosed with ATTR-CA over the past 20 years.| File | Dimensione | Formato | |
|---|---|---|---|
|
CIRCULATIONAHA.122.060852.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
1.81 MB
Formato
Adobe PDF
|
1.81 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
